Drug
Pg4
Pg4: highest development phase Phase 3, developed by Pfizer. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Pfizer
Trials
| Drug | Phase | Indication |
|---|---|---|
| PG4 NCT07573462 | Phase 3 | Pneumococcal Disease |
| PG4 NCT06524414 | Phase 2 | Pneumococcal Disease |
Latest
No recent events.
Follow Pg4 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.